Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
SillaJen Inc (215600 KS)
Watchlist
52
Analysis
Health Care
•
South Korea
SillaJen, Inc. provides medical research and development services. The Company researches and develops treatment of cancer based on genetic recombination virus. SillaJen conducts its business in South Korea and the United States.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Quantitative Analysis
•
18 Dec 2019 13:00
Korea Shorts Data Analysis (#4): MOBIS, Celltrion, SEMCO, Fila Korea & LG Uplus
This is our 4th edition of the Korea Shorts Data Analysis. We broke down the Korean shorts data analysis that are available on KRX (data as of...
Douglas Kim
Follow
767 Views
Share
bearish
•
Quantitative Analysis
•
02 Dec 2019 16:06
Korea Shorts Data Analysis (#3): LG H&H, Amorepacific, KMW, Hotel Shilla, & DSINFRA
This is our third edition of the Korea Shorts Data Analysis. We broke down the Korean shorts data analysis that are available on KRX (data as of...
Douglas Kim
Follow
540 Views
Share
bearish
•
Quantitative Analysis
•
18 Nov 2019 11:37
Korea Shorts Data Analysis (#2): HLB, Fila Korea, DS Infracore, Helixmith, Korea Kolmar, & Cosmax
This is our second edition of the Korea Shorts Data Analysis. We broke down the Korean shorts data analysis that are available on KRX (data as of...
Douglas Kim
Follow
532 Views
Share
bearish
•
Quantitative Analysis
•
01 Nov 2019 22:11
Korea Shorts Data Analysis (#1): Celltrion, Samsung Biologics, DS Infracore, HLB, & Hotel Shilla
This is our first inaugural edition of the Korea Shorts Data Analysis. We plan to make this into a regular piece. We broke down the Korean shorts...
Douglas Kim
Follow
565 Views
Share
bearish
•
KMW Co Ltd
•
26 Oct 2019 21:03
KMW - What's Up Next After Nokia Earnings Disaster?
Kmw Co Ltd (032500 KS), a Korean telecom equipment maker, had a terrible week last week. Its share price fell 17.8% last week and 15.5% on Friday...
Douglas Kim
Follow
587 Views
Share
First
Previous
4
5
6
7
8
9
10
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x